Jennifer Selever, Ph.D. - Publications

Affiliations: 
Molecular & Human Genetics Baylor College of Medicine, Houston, TX 
Area:
Neurodevelopment

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Patel JM, Swanson J, Ung K, Herman A, Hanson E, Ortiz-Guzman J, Selever J, Tong Q, Arenkiel BR. Sensory perception drives food avoidance through excitatory basal forebrain circuits. Elife. 8. PMID 31074744 DOI: 10.7554/Elife.44548  0.319
2019 Cassidy RM, Lu Y, Jere M, Tian JB, Xu Y, Mangieri LR, Felix-Okoroji B, Selever J, Xu Y, Arenkiel BR, Tong Q. A lateral hypothalamus to basal forebrain neurocircuit promotes feeding by suppressing responses to anxiogenic environmental cues. Science Advances. 5: eaav1640. PMID 30854429 DOI: 10.1126/Sciadv.Aav1640  0.309
2016 Herman AM, Ortiz-Guzman J, Kochukov M, Herman I, Quast KB, Patel JM, Tepe B, Carlson JC, Ung K, Selever J, Tong Q, Arenkiel BR. A cholinergic basal forebrain feeding circuit modulates appetite suppression. Nature. PMID 27698417 DOI: 10.1038/Nature19789  0.341
2013 Covington KR, Brusco L, Barone I, Tsimelzon A, Selever J, Corona-Rodriguez A, Brown P, Kumar R, Hilsenbeck SG, Fuqua SA. Metastasis tumor-associated protein 2 enhances metastatic behavior and is associated with poor outcomes in estrogen receptor-negative breast cancer. Breast Cancer Research and Treatment. PMID 24077732 DOI: 10.1007/S10549-013-2709-5  0.414
2011 Selever J, Gu G, Lewis MT, Beyer A, Herynk MH, Covington KR, Tsimelzon A, Dontu G, Provost P, Di Pietro A, Boumendjel A, Albain K, Miele L, Weiss H, Barone I, et al. Dicer-mediated upregulation of BCRP confers tamoxifen resistance in human breast cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 6510-21. PMID 21878538 DOI: 10.1158/1078-0432.Ccr-11-1403  0.43
2011 Barone I, Brusco L, Gu G, Selever J, Beyer A, Covington KR, Tsimelzon A, Wang T, Hilsenbeck SG, Chamness GC, Andò S, Fuqua SA. Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α. Journal of the National Cancer Institute. 103: 538-52. PMID 21447808 DOI: 10.1093/Jnci/Djr058  0.419
2010 De Amicis F, Thirugnansampanthan J, Cui Y, Selever J, Beyer A, Parra I, Weigel NL, Herynk MH, Tsimelzon A, Lewis MT, Chamness GC, Hilsenbeck SG, Andò S, Fuqua SA. Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells. Breast Cancer Research and Treatment. 121: 1-11. PMID 19533338 DOI: 10.1007/S10549-009-0436-8  0.44
2009 Selever J, Barone I, Lewis MT, Corona-Rodriguez A, Tsimelzon A, Di Pietro A, Boumemdjel A, Fuqua S. Effect of estrogen receptor-positive progenitor cells on a tamoxifen resistance phenotype in breast cancer cells. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 1042. PMID 27961120 DOI: 10.1200/Jco.2009.27.15_Suppl.1042  0.439
2009 Barone I, Cui Y, Herynk MH, Corona-Rodriguez A, Giordano C, Selever J, Beyer A, Andò S, Fuqua SA. Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway. Cancer Research. 69: 4724-32. PMID 19487288 DOI: 10.1158/0008-5472.Can-08-4194  0.427
Show low-probability matches.